Massimo Loda
Massimo Loda
Professor of Pathology, Harvard Medical School
Verifierad e-postadress på
Citeras av
Citeras av
The landscape of somatic copy-number alteration across human cancers
R Beroukhim, CH Mermel, D Porter, G Wei, S Raychaudhuri, J Donovan, ...
Nature 463 (7283), 899-905, 2010
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses
A Bhattacharjee, WG Richards, J Staunton, C Li, S Monti, P Vasa, C Ladd, ...
Proceedings of the National Academy of Sciences 98 (24), 13790-13795, 2001
Gene expression correlates of clinical prostate cancer behavior
D Singh, PG Febbo, K Ross, DG Jackson, J Manola, C Ladd, P Tamayo, ...
Cancer cell 1 (2), 203-209, 2002
Integrative clinical genomics of advanced prostate cancer
D Robinson, EM Van Allen, YM Wu, N Schultz, RJ Lonigro, JM Mosquera, ...
Cell 161 (5), 1215-1228, 2015
Multiclass cancer diagnosis using tumor gene expression signatures
S Ramaswamy, P Tamayo, R Rifkin, S Mukherjee, CH Yeang, M Angelo, ...
Proceedings of the National Academy of Sciences 98 (26), 15149-15154, 2001
Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines
MF Kane, M Loda, GM Gaida, J Lipman, R Mishra, H Goldman, JM Jessup, ...
Cancer research 57 (5), 808-811, 1997
The molecular taxonomy of primary prostate cancer
A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ...
Cell 163 (4), 1011-1025, 2015
Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
M Loda, B Cukor, SW Tam, P Lavin, M Fiorentinc, GF Draetta, JM Jessup, ...
Nature medicine 3 (2), 231-234, 1997
High-throughput oncogene mutation profiling in human cancer
RK Thomas, AC Baker, RM DeBiasi, W Winckler, T LaFramboise, WM Lin, ...
Nature genetics 39 (3), 347-351, 2007
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways
PK Majumder, PG Febbo, R Bikoff, R Berger, Q Xue, LM McMahon, ...
Nature medicine 10 (6), 594-601, 2004
Control of TH 2 polarization by the chemokine monocyte chemoattractant protein-1
L Gu, S Tseng, RM Horner, C Tam, M Loda, BJ Rollins
Nature 404 (6776), 407-411, 2000
Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer
RE Reiter, Z Gu, T Watabe, G Thomas, K Szigeti, E Davis, M Wahl, ...
Proceedings of the National Academy of Sciences 95 (4), 1735-1740, 1998
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
Q Wang, W Li, Y Zhang, X Yuan, K Xu, J Yu, Z Chen, R Beroukhim, ...
Cell 138 (2), 245-256, 2009
Targeting potential drivers of COVID-19: Neutrophil extracellular traps
BJ Barnes, JM Adrover, A Baxter-Stoltzfus, A Borczuk, J Cools-Lartigue, ...
Journal of Experimental Medicine 217 (6), 2020
Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage
ME McMenamin, P Soung, S Perera, I Kaplan, M Loda, WR Sellers
Cancer research 59 (17), 4291-4296, 1999
Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease
DA Weinstein, CN Roy, MD Fleming, MF Loda, JI Wolfsdorf, NC Andrews
Blood, The Journal of the American Society of Hematology 100 (10), 3776-3781, 2002
CpG island methylator phenotype, microsatellite instability, BRAF mutation and clinical outcome in colon cancer
S Ogino, K Nosho, GJ Kirkner, T Kawasaki, JA Meyerhardt, M Loda, ...
Gut 58 (1), 90-96, 2009
Essential roles of PI (3) K–p110β in cell growth, metabolism and tumorigenesis
S Jia, Z Liu, S Zhang, P Liu, L Zhang, SH Lee, J Zhang, S Signoretti, ...
Nature 454 (7205), 776-779, 2008
p63 is a prostate basal cell marker and is required for prostate development
S Signoretti, D Waltregny, J Dilks, B Isaac, D Lin, L Garraway, A Yang, ...
The American journal of pathology 157 (6), 1769-1775, 2000
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent
K Xu, ZJ Wu, AC Groner, HH He, C Cai, RT Lis, X Wu, EC Stack, M Loda, ...
Science 338 (6113), 1465-1469, 2012
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20